Clinical trial · Observational
Assessing the Feasibility of Screening and Treating Anxiety and Depression in the Bone Marrow Transplant Population
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary purpose of this study is twofold: (1) to assess the feasibility of screening adult hematopoietic stem cell transplantation (HSCT) candidates for psychiatric comorbidity (depression and anxiety), and (2) to assess the feasibility of treating depression and anxiety in adult HSCT candidates through a collaborative care algorithm. The ultimate goal of this project is improving HSCT outcomes for allogeneic HSCT candidates by improving identification and treatment of depression and anxiety disorders.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety | — | UNRESOLVED | — |
| Depression | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Allogeneic Transplant
- description
- All patients seen in the UNC Bone Marrow Transplant clinic who are candidates for allogeneic transplantation attending their pre-admission visit were approached to offer study participation. Study participation included completion of surveys over a time period up to 60 days after their transplant.
Primary outcomes (1)
- measure
- Systematic screening for depression and anxiety using the Hospital Anxiety and Depression Scale
- timeFrame
- Day 0
- description
- Assess the feasibility of systematic screening for depression and anxiety using the Hospital Anxiety and Depression Scale in adult patients who are allogeneic HSCT candidates.
Secondary outcomes (3)
- measure
- Satisfaction among patients and providers participating in the collaborative care model
- timeFrame
- Day 0
- description
- Assess the feasibility of implementing a collaborative care model through assessment of intervention satisfaction scores among participating patients and their health care providers.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * hematological or non-hematological malignancy * plan to receive an allogeneic stem cell transplant * patient at UNC's ambulatory BMT clinic * able to complete self-report measures * English speaking Exclusion Criteria: * plan to receive an autologous transplant * plan to receive allogeneic transplant for a non-malignancy * unable to complete self report measures in English * pregnant * pre-existing diagnoses of bipolar affective disorder, schizoaffective disorder or schizophrenia
References
Publications (0)
Data not yet available